Subscribe Now Subscribe Today
Research Article
 

Study of Protein Binding of Levofloxacin in Human Beings



Sheikh, M.A., S. Khanum, A. Ahmad, T. Iqbal, Z. Hydair and Shakeela Naz
 
Facebook Twitter Digg Reddit Linkedin StumbleUpon E-mail
ABSTRACT

Levofloxacin is a quinolone antimicrobial which acts through the inhibition of bacterial topoisomerases that has been developed mostly for clinical use in human medicine. Its protein binding was investigated in human beings under indigenous conditions. Drug concentration of 1, 2, 3, 4 and 5 g/ml were added to the plasma and binding of levofloxacin was determined by ultrafiltration and its concentration in ultrafiltrates was determined by microbiological assay. The binding of levofloxacin showed positive correlation between drug concentration and percentage bound drug and maximum binding was observed at 5 g/ml and 59% in human beings. The pH of plasma also affected the binding, being highest at 7.4 in human beings, and it was 53%. In vitro binding of levofloxacin was maximum at normal level of blood protein.

Services
Related Articles in ASCI
Search in Google Scholar
View Citation
Report Citation

 
  How to cite this article:

Sheikh, M.A., S. Khanum, A. Ahmad, T. Iqbal, Z. Hydair and Shakeela Naz, 2001. Study of Protein Binding of Levofloxacin in Human Beings. Journal of Medical Sciences, 1: 87-90.

DOI: 10.3923/jms.2001.87.90

URL: https://scialert.net/abstract/?doi=jms.2001.87.90

Introduction

In systemic circulation and tissues, some concentrations of the drug may bind with plasma and tissue proteins. Plasma protein and It may significantly affects the distribution, biodisposition clearance and action of the drug (Lindup, 1975). Forces involved in the binding of drugs include ion-ion interactions, hydrogen bonding, dipole-dipole interactions and vander waal forces (Ladu, 1972). Many drugs are bound to plasma protein, mostly acidic drugs to plasma albumin and basic drugs to α-acid glycoproteins, binding to other plasma proteins generally occur to much smaller extent (Gillman, 1985). There is a dynamic equilibrium between the bound and free drug. When free drug leave the circulation, bound drug is released to restore the balance and bound drug can be regarded as storage depot (Brander et al., 1991).

The difference in geonetics make the difference in proteins concentration and type between indigenous and exogenous populations. These genetic factors affects the pharmacokinetics and pharmacodynamics of the drugs.

Levofloxacin is a flouroquinolone antibiotic, having broad spectrum of in vitro activity against gram-positive and gram-negative bacteria. Levofloxacin like other flouroquinolones, exerts its antibacterial effects through inhibition of deoxyribonucleic acid (DNA) gyrase, a type of II topoisomerase. Levofloxacin is widely distributed in body with a mean volume of distribution 1.1L/kg (Fish and Chow, 1997). So, protein binding of levofloxacin in human beings was investigated to see the effect of drug concentration, plasma protein concentration, and plasma pH on the protein binding, under indigenous conditions.

Materials and Methods

Plasma protein binding of levofloxacin was determined by using blood samples of human beings. Human blood was obtained from the blood bank of Allied Hospital, Faisalabad and Chiniot Dialysis Center, Faisalabad. The blood samples were collected in test tubes containing heparin at the rate of one drop per 10 ml of the blood sample. Blood samples were centrifuged at 3000 rpm for 10-20 min. and plasma was separated for protein binding studies. Pure levofloxacin was obtained from Hilton Pharma Pvt. Ltd., Karachi. The stock solution of 100mg/100ml was prepared in deionized water. The protein binding of levofloxacin was determined by ultrafiltration through a cellophane membrane of pore size 20-80°A. The pores would permit the molecules upto 5000 molecular weight to pass through the membrane (Poulson, 1956). The influence of drug concentration, plasma pH and protein concentrations, biuret reaction (Gornall et al., 1949) was determined. The concentration of levofloxacin in standard solutions and ultrafiltrates was estimated by microbiologicl assay according to disc agar diffusion method (Arret et al., 1971) using Staphylococcus aureus as test organism.

Results and Discussion

Influence of drug concentration on binding: In human beings, binding of levofloxacin has increased with increasing drug concentration. At 1Fg/ml, binding was 38% or 38Fg/ml to plasma proteins, as drug concentration increased from 1 to 2 Fg/ml, binding was increased and become 48% of the total drug. At 3, 4, and 5 Fg/ml binding was 52, 54 and 59% respectively. Binding was highest at 5Fg/ml (Table 1). With increase in drug concentration (moles) the % bound of the drug was also increased (Fig. 1). Under normal condition with increase in drug concentration, binding also increased but after saturation, no further increase is found. Low drug concentration, used in this study are much lower than the saturation points. At 5 Fg/ml the binding of levofloxacin studied (Fish and Chow, 1997) was 24-38%. The difference may be due to genetic factors.

Effect of plasma pH on binding: The binding of levofloxacin in human being maximum at pH 7.4 (53%) which is the normal pH of human plasma. At pH 7.2, 7.3, 7.5 and 7.6 binding of Levofloxacin was 37, 48, 41 and 34% as represented by Fig. 2 and Table 3. The pH below 7.3 leads to acidosis and above 7.5 leads to alkalosis (Chatterjea and Shinde, 1993). However, in animals a pH range of 7.00 to 7.80 have been stated as compatible with life range (Pitts, 1966) and animals tolerate variations (Nawaz and Shah, 1985). The indigenous cows, goats and sheep showed even longer variation and higher values of blood pH (Nawaz et al., 1988). The pH change in plasma can change the ionization characteristics of both drug and protein. In any particular interactions, either ionized or non-ionized groups of both drug and protein involved in the reactions and very complex pH effects can result (Curry, 1977). Theoretically all changed sites of albumin acts as binding sites and change in pH, change these binding sites and hence binding of the drugs. The % values of protein bindings is 35, 32% at 10 and 20% dilution and 41, 45% at 10 and 20% concentration respectively as shown in Table 3 and Fig. 3.

Effect of plasma protein concentration on binding: A graphic representation of protein binding of levofloxacin at various protein concentrations is shown in Fig. 4. Curry (1977) was investigated that most organic compounds used as drugs interact with albumin and not bound to a significant amount to other plasma protein and any change in plasma protein effect the binding of drugs to the proteins.

Image for - Study of Protein Binding of Levofloxacin in Human Beings
Fig. 1: Curve showing the effecto fo drug concentration on in vitro plasma protein binding of levofloxacin in human begins

Amount and type of plasma protein vary in different species and even in individuals (Kaneko, 1980). The effect on protein binding becomes important when drug binding capacity of albumin molecules or concentration is abnormally low (McLaren, 1982). The low level of albumin in human has exhibited poor protein binding of tetracyclines in blood, so rapid elimination and clearance of drug from the body (Raghuan and Krishnaswamy, 1981). In vitro protein binding of levofloxacin was increased by increasing protein concentration because more binding sites available and binding decreased when protein concentration low because of decreased binding sites. These variations may be attributed to the change in the micro environment of binding sites resulting differences in binding.

Table 1: Showing molar concentration of levofloxacin and its binding with plasma protein in human
Image for - Study of Protein Binding of Levofloxacin in Human Beings
M= Moles of drug; r= Moles of drug bound per moles of albumin; D= free moles of drug

Table 2: Influence of pH on binding of levofloxacin
Image for - Study of Protein Binding of Levofloxacin in Human Beings

Table 3: Influence of protein concentration on binding levofloxacin
Image for - Study of Protein Binding of Levofloxacin in Human Beings

Image for - Study of Protein Binding of Levofloxacin in Human Beings
Fig. 2: Curve showing the effect of pH on in vitro plasma protein binding of levofloxacin in human beings

Image for - Study of Protein Binding of Levofloxacin in Human Beings
Fig. 3: Curve showing the effect of plasma protein concentration on in vitro plasma protein binding of levofloxacin in human beings

Image for - Study of Protein Binding of Levofloxacin in Human Beings
Fig. 4: Curve showing the effect of plasma protein concentration in vitro plasma protein binding of levofloxacin in human beings

It should be needed to determine the protein binding of drugs under indigenous conditions to evaluate the drugs.

REFERENCES

1:  Arret, B., D.D. Johnson and K. Amiel, 1971. Outlines of detail for microbiological assay of antibiotics. J. Pharm. Sci., 60: 373-378.

2:  Brander, G.C., D.M. Pugh, R.J. Bywater and W.L. Jenkins, 1991. Veterinary Applied Pharmacology and Therapeutics. 5th Edn., Bailliere Tindall, London
Direct Link  |  

3:  Curry, S.H., 1977. Drug Disposition and Pharmacokinetics with a Consideration of Pharmacological and Clinical Relationships. 2nd Edn., Blackwell Scientific Publ., UK

4:  Chatterjea, M.N. and R. Shinde, 1993. Textbook of Medical Biochemistry. Jaypee Brothers Medical Publ., New Dehli, pp: 108-116

5:  Fish, D.N. and A.T. Chow, 1997. The clinical pharmacokinetics of levofloxacin. Clin. Pharmacokinet., 32: 101-119.
PubMed  |  Direct Link  |  

6:  Gilman, A.G., L.S. Goodman, T.W. Rall and F. Murad, 1985. The Pharmacological Basis of Therapeutics. 7th Edn., Macmillian Publishing Co., New York, USA., Pages: 1629

7:  Gornall, A.G., C.J. Bardawill and M.M. David, 1949. Determination of serum proteins by means of the biuret reaction. J. Biol. Chem., 177: 751-766.
PubMed  |  Direct Link  |  

8:  Kaneko, J.J., 1980. Clinical Biochemistry of Domestic Animals. 3rd Edn., Academic Press, New York, USA

9:  Ladu, B.N., H.G. Mandel and E.L. Way, 1972. Fundamentals of Drug Metabolism and Drug Disposition. Williums and Wilkins Co., Baltimore

10:  Lindup, W.E., 1975. Drug-albumin binding. Biochem. Soc. Trans., 3: 635-640.
CrossRef  |  Direct Link  |  

11:  Mclaren, D., 1982. Nutrition and its Disorders. 3rd Edn., Churchill Livingstone, Edinburgh

12:  Pitts, R.F., 1966. Physiology of the Kidney and Body Fluids. Year Book Publishers, Chicago

13:  Poulson, E., 1956. Renal Clearance in Cows. Oxford University Press, New York

14:  Raghuan, T.C. and K. Krishnaswmy, 1981. Tetracycline kinetics in undernourished subjects. J. Clin. Pharmacol. Ther. Toxicol., 19: 409-413.
PubMed  |  Direct Link  |  

15:  Nawaz, M. and B.H. Shah, 1985. Geonetica considerations in the quality assurance of pharmaceuticals. Proceedings of the International Seminar on Policies Management and Quality Assurance of Pharmaceuticals, April 21-25.

16:  Nawaz, M., I. Tahira and N. Rakhshanda, 1988. Geonetical considerations in disposition kinetics evolution of chemotherapeutic agents vetanianary pharmacology toxicol and therapy in food producing animals. Proceedings of the 4th Congerious Europe Association Veterinary Pharmacology and Toxicology, August 28-September 2, 1988, Budapest, pp: 260-

©  2022 Science Alert. All Rights Reserved